Table S1.
Association of NPTX1 expression with the GC clinicopathological characteristics in GSE62254 cohort
| N (300) | NPTX1 expression level
|
P-value | ||
|---|---|---|---|---|
| Low [n (%)] | High [n (%)] | |||
| Gender | 0.014 | |||
| Female | 101 | 40 (39.6) | 61 (60.4) | |
| Male | 199 | 110 (55.3) | 89 (44.7) | |
| Age (years) | 0.018 | |||
| ≤60 | 117 | 48 (41.0) | 69 (59.0) | |
| >60 | 183 | 102 (55.7) | 81 (44.3) | |
| Tumor stage | 0.022 | |||
| T1–T3 | 279 | 145 (52.0) | 134 (48.0) | |
| T4 | 21 | 5 (23.8) | 16 (76.2) | |
| Lymph node stage | 0.011 | |||
| N0 | 38 | 25 (65.8) | 13 (34.2) | |
| N1–N3 | 262 | 125 (47.7) | 137 (52.3) | |
| Metastasis stage | 0.158 | |||
| M0 | 273 | 140 (51.3) | 133 (48.7) | |
| M1 | 27 | 10 (37.0) | 17 (63.0) | |
Note: Bold values indicate statistical significance, P<0.05.
Abbreviation: GC, gastric cancer.